TMP001 in relapsing-remitting multiple sclerosis: a multicentre open, baseline-controlled phase IIa clinical trial TMP001 in relapsing-remitting multiple sclerosis: a multicentre open, baseline-controlled phase IIa ...
TMP001 in relapsing-remitting multiple sclerosis: a multicentre open, baseline-controlled phase IIa clinical trial TMP001 in relapsing-remitting multiple sclerosis: a multicentre open, baseline-controlled phase IIa ...
Patients with defined diagnosis of relapsing-remitting multiple sclerosis and at least 1 documented relapse during the previous year OR at least 2 documented relapses during the previous 2 years. MedDRA version: 19.0;Level: PT;Classification code 10063399;Term: Relapsing-remitting multiple sclerosis;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Patients with defined diagnosis of relapsing-remitting multiple sclerosis and at least 1 documented ...
Product Name: Tarenflurbil Product Code: TMP001 INN or Proposed INN: Tarenflurbil Other descriptive name: FLURBIPROFENProduct Name: Tarenflurbil Product Code: TMP001 INN or Proposed INN: Tarenflurbil Other descriptive nam ...
Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME) Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Eco ...